MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.230
-0.010
-0.45%
After Hours: 2.230 0 0.00% 16:10 07/24 EDT
OPEN
2.300
PREV CLOSE
2.240
HIGH
2.320
LOW
2.160
VOLUME
384.40K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
2.030
MARKET CAP
226.96M
P/E (TTM)
-2.7060
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACIU last week (0713-0717)?
Weekly Report · 4d ago
Weekly Report: what happened at ACIU last week (0706-0710)?
Weekly Report · 07/13 09:30
AC Immune Announces Three Presentations At The Alzheimer's Association International Conference, July 12-15
Benzinga · 07/07 11:08
AC Immune to present early human data for first-in-class TDP-43 PET tracer at AAIC 2026
PUBT · 07/07 11:01
Weekly Report: what happened at ACIU last week (0629-0703)?
Weekly Report · 07/06 09:31
AC Immune: Holding Into A Make-Or-Break H2 2026 Readout
Seeking Alpha · 07/02 11:15
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Niagen Bioscience (NAGE) and AC Immune SA (ACIU)
TipRanks · 07/01 10:30
AC Immune Unveils 12-Month Interim Data from ACI-24 Alzheimer’s Trial and Expands Takeda-Backed Program
TipRanks · 06/30 13:38
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.